John L. Colombo

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 291 citations

Pulmonary Fibrosis, Medicine, Placebo-controlled Phase 3

Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

Richard B. Moss, Carlos Milla, John L. Colombo et al. · Human Gene Therapy · 2007 · 267 citations

Recurrent aspiration in children: Lipid‐laden alveolar macrophage quantitation

John L. Colombo, Timothy K. Hallberg · Pediatric Pulmonology · 1987 · 175 citations

Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis

David R. Mack, Monica D. Traystman, John L. Colombo et al. · The Journal of Pediatrics · 1995 · 77 citations

Hepatology, Biliary Tract, Liver Physiology +10

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 59 citations

Advanced Lung Disease, Forced Expiratory Volume, Pulmonary Physiology +6